Open Orphan PLC
LSE:ORPH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Open Orphan PLC
LSE:ORPH
|
UK |
|
R
|
Royal Holdings Co Ltd
TSE:8179
|
JP |
|
C
|
Cliffside Capital Ltd
XTSX:CEP
|
CA |
|
Q
|
Qingdao Kutesmart Co Ltd
SZSE:300840
|
CN |
|
Shenzhen H&T Intelligent Control Co Ltd
SZSE:002402
|
CN |
|
B
|
Benares Hotels Ltd
BSE:509438
|
IN |
Open Orphan PLC
Open Orphan Plc provides pharmaceutical development services. The firm is engaged in the testing of vaccines and antivirals using human clinical trials. The firm has a presence in the United Kingdom, Ireland, France and Netherlands. The Company, through its subsidiary hVIVO Limited, is also engaged in the data platform business. hVIVO Limited has built up databases of infectious disease progression data and the Company is populating its Open Orphan Health Data platform with hVIVO data. The firm also operates through its subsidiary Venn Life Sciences, which is an integrated drug development partner. Venn Life Sciences offers a combination of drug development consultancy, clinical trial design and execution to create, plan and execute drug development programs for its customers.
Open Orphan Plc provides pharmaceutical development services. The firm is engaged in the testing of vaccines and antivirals using human clinical trials. The firm has a presence in the United Kingdom, Ireland, France and Netherlands. The Company, through its subsidiary hVIVO Limited, is also engaged in the data platform business. hVIVO Limited has built up databases of infectious disease progression data and the Company is populating its Open Orphan Health Data platform with hVIVO data. The firm also operates through its subsidiary Venn Life Sciences, which is an integrated drug development partner. Venn Life Sciences offers a combination of drug development consultancy, clinical trial design and execution to create, plan and execute drug development programs for its customers.
